Odai Sinokrot

Pulmonary and Critical Care Medicine

[Odai Sinokrot @OSinokrot]

Join us for the annual Lung Cancer Symposium hosted by Maimonides Medical Center this coming Friday!

📅 October 31, 2025
🕣 7:00AM–1:30 PM
📍 Maimonides Medical Center
Schreiber Auditorium
In person and virtual options available
Free registration and login
@MaimoHealth

[Odai Sinokrot @OSinokrot]

@CCF_IMCHIEFS The best!

[NYULangonePCCSM @NYULangonePCCSM]

Leadership is about saying 'yes' to opportunities that shape your path & legacy. 💡 Hear from Dr. Doreen Addrizzo-Harris as she shares her journey, insights, & lessons in leadership on the #AllPhysiciansLead podcast 🎙️✨

🎧 to Part 2 👉 https://t.co/4mWUhmcKfB
#Meded

[Naftali Kaminski @KaminskiMed]

A great step for #CureIPF!!! INTEGRIS-IPF, a phase IIa #RCT suggests that Bexotegrast, an αvβ6 & αvβ1 inhibitor has safety & dose-dependent efficacy. Can't wait for Phase III results. Kudos Drs Lancaster, Flaherty, #IntegrisIPF team & @ATSBlueEditor! https://t.co/2nAdRumTph

[Pulm PEEPs @PulmPEEPs]

Thanks for all the input and for listening to our case files! This patient with a green exudative pleural effusion had it from RA!

👇infographic on pulmonary manifestations of RA

[Pulm PEEPs @PulmPEEPs]

You should have Sarcoidosis, Cystic Fibrosis (CF), Hypersensitivity Pneumonitis (HP) and Lymphangioleiomyomatosis (LAM) on the differential

[Mithu Maheswaranathan, MD @MithuRheum]

🆕 Let’s Learn about Sarcoidosis!
Created with @mwsharp5

⭐️ Sarcoidosis = inflammatory condition characterized by NON-necrotizing granulomas
• multi-system involvement 🫁🫀🧠👁️
• April is Sarcoidosis Awareness Month!

#RheumTwitter #PulmTwitter #MedX

[Radiopaedia.org @Radiopaedia]

Is your understanding of mosaic attenuation in the lungs on CT a little hazy or patchy?

These are just a few slides from @StefanTigges and Eugene Berkowitz's award-winning rPoster, free to view on our website at https://t.co/ZzwSKhATCA

#chestrad #FOAMrad

[jpedrokessner @KessnerJp]

Interstitial Lung Disease: @JAMANetwork @JAMANetworkOpen @JAMA_current
https://t.co/RGCuLzGuMM
😱🫁🩺🔦🎞📉🩸🧪🔬🥶🐍🐦💊📚
@atscommunity @EuroRespSoc @ALATorax @SPLF_SocPneumo @pneumosbpt @SeparRespira @AeerNeumologia @NeumoMadrid @socapnet

[NYULangonePCCSM @NYULangonePCCSM]

The #LungCancer team @Perlmutter_CC recently partnered with @Medscape to discuss the latest ground-breaking innovations in early detection & treatment of lung cancer. Learn how our team is streamlining & revolutionizing cancer care with
@StermanDaniel ➡️ https://t.co/OR2WBW510x

[Odai Sinokrot @OSinokrot]

@JakeNatalini @Leopoldo_Segal Congrats Jake!

[NYULangonePCCSM @NYULangonePCCSM]

A multidisciplinary team including our own @rany_condos Describe Pulmonary Crohn's Disease Masquerading as Lymphoma in @ACGCRJ

🔓 https://t.co/RwnsyONOty
#gastroenterology #ILD #Pulmonary #PCCM #Lung #Lungdisease

[jpedrokessner @KessnerJp]

Fibrotic Interstitial Lung Disease (FILD): ICU Management.
https://t.co/b84u2See3D
🫁😱🎞🗣
@accpchest @journal_CHEST @atscommunity @EuroRespSoc @ALATorax @NeumoMadrid @neumopararesis @BTSrespiratory @SPLF_SocPneumo @pneumosbpt @HUReinaSofia @NeumoNat @MarisolArLa @SeparRespira

[ATS Clinical Problems Assembly @ATSCPAssembly]

ICYMI the Race in PFT Interpretation webinar is now available ➡️https://t.co/l0Qn5zF1cW

Speakers: Nirav R. Bhakta, MD
Gabrielle Y. Liu, MD, MS
Aaron D. Baugh, MD
Stephanie Lovinsky-Desir, MD, MS

Moderated by: Anthony Esposito, MD and Lijo C. Illipparambil, MD, MS.

Highlights⏬

[Emily Fridenmaker @emily_fri]

One of my favorite review articles that I reread and send to fellows often. So many good CT and path images.

Cavitary Lung Diseases - CHEST https://t.co/W7vXHhDbRY

[American Thoracic Society (ATS) @atscommunity]

Have you heard of e-cigarette/vaping product-use associated lung injuries (EVALI)?🤔🫁There are many risks associated with vaping, regardless of the device used. Swipe👉 thru these excerpts from our Patient Fact Sheet on EVALI to learn more.

🔗Full sheet: https://t.co/H40UVPOGlr

[jpedrokessner @KessnerJp]

Guideline for Pleural Disease: @BTSrespiratory
https://t.co/u1TyJDpwFs
🫁🎞🔦🧫🧪🧬⚔️⚖️
@Lungeninfo @atscommunity @EuroRespSoc @SeparRespira @NeumoNat @NeumoMadrid @socapnet @ALATorax @AlatImagenes @SPLF_SocPneumo @pneumosbpt @pneumobell @HUReinaSofia @NeumoIntervHURS

[Rami Manochakian MD, FASCO Cancer Education @RManochakian]

#LCSM #LCAM
@LungCancerRx @esinghimd @OncBrothers @oncodaily @n8pennell @DrRiyazShah @GlopesMd @NarjustFlorezMD @ADesaiMD @Alfdoc2 @acmoorephd @ChristianRolfo @CharuAggarwalMD @Latinamd @DrSanjayPopat @DrSteveMartin @NaglaAKarimMD @AboutLungCancer @HemOncFellows @DevikaDasMD @drgandara @drshieldsmd @HosseinBorghaei @RamalingamMD @ns_chd @FawziAbuRous @LuisRaezMD @DRCamidge @DipeshUpretyMD @MLJohnsonMD2 @MMarmarelis @bensolomon1 @herbloong @tnewsomdavis @BoschBarrera @MarceloCorassa @oncologician @g_mountzios @HHorinouchi @Tony_Calles @DrZ_84 @APassaroMD @lcrf_org @lcfamerica @LungCancerFaces @chulkimMD @HemOncFellows

[Elliot Servais, MD, FACS @ElliotServaisMD]

@RManochakian @LungCancerRx @esinghimd @OncBrothers @oncodaily @n8pennell @DrRiyazShah @GlopesMd @NarjustFlorezMD @ADesaiMD @Alfdoc2 @acmoorephd @ChristianRolfo @CharuAggarwalMD @Latinamd @DrSanjayPopat @DrSteveMartin @NaglaAKarimMD @AboutLungCancer @HemOncFellows @DevikaDasMD Great step in the right direction!

@NCCN guidelines eliminate 15yr quit time limit AND upper age limit.
If we Tx pts >80yrs age, why not screen?

Also, remember CMS coverage based on USPSTF, so this ACS update does not guarantee coverage.
This is a call to action for advocacy!!

[Zeina Nahleh, MD, FACP @drznahleh]

November is #LungCancerAwarenessMonth Less than 10 % of eligible people in the US receive this life saving screening @LungAssociation
Time to increase lung cancer screening rates and awareness!! Thank you @RManochakian @NaglaAKarimMD @DrAlexAdjei @n8pennell @CleveClinicFL